Kymera Therapeutics, Inc.

KYMR · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$120,256$109,966$68,395$47,976
Short-Term Investments$368,488$264,915$338,771$394,442
Receivables$947$18,762$2,537$135
Inventory$0$0$0$0
Other Curr. Assets$20,577$11,674$9,713$8,720
Total Curr. Assets$510,268$405,317$419,416$451,273
Property Plant & Equip (Net)$97,864$101,079$22,243$21,307
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$362,159$61,434$152,328$125,187
Tax Assets$0$0$0$0
Other NC Assets$7,744$7,929$9,147$8,138
Total NC Assets$467,767$170,442$183,718$154,632
Other Assets$0$0$0$0
Total Assets$978,035$575,759$603,134$605,905
Liabilities
Payables$5,989$7,075$4,335$4,005
Short-Term Debt$13,112$6,345$3,943$3,599
Tax Payable$0$0$0$0
Deferred Revenue$13,576$37,883$35,260$61,739
Other Curr. Liab.$35,090$34,388$27,805$23,199
Total Curr. Liab.$67,767$85,691$71,343$92,542
LT Debt$74,649$78,329$13,392$14,364
Deferred Rev, NC$0$16,768$28,000$39,295
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$248$66
Total NC Liab.$74,649$95,097$41,640$53,725
Other Liabilities$0$0$0$0
Cap. Leases$87,761$84,674$17,335$17,963
Total Liabilities$142,416$180,788$112,983$146,267
Equity
Pref Stock$0$0$0$0
Common Stock$7$6$6$5
Retained Earnings-$754,610-$530,752-$383,790-$228,982
AOCI-$1,485-$552-$4,949-$660
Other Equity$1,591,707$926,269$878,884$689,275
Total Equity$835,619$394,971$490,151$459,638
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$978,035$575,759$603,134$605,905
Net Debt-$32,495-$25,292-$51,060-$30,013